Research map: Evaluating Circulating DNA as a Prognostic Biomarker in Bladder Cancer Subtypes: A Preliminary Short Report

Back to the article

Papers in this map

  1. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer · Thomas Reinert · 2019 · 1054 citations · Cited by this paper
  2. CT-Measured Psoas Area Predicts Urinary Incontinence Trajectories and Persistence After Robotic Prostatectomy: A 12-Month Analysis Using the 1-Hour Pad Test · 2026 · Related
  3. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma · Thomas B. Powles · 2023 · 152 citations · Cited by this paper
  4. Age at Diagnosis and Postoperative Outcomes among Men Treated for Prostate Cancer in the U.S. Military Health System · 2026 · Related
  5. ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer · Thomas B. Powles · 2025 · 143 citations · Cited by this paper
  6. Circulating Tumor DNA After Radical Cystectomy as a Marker of Minimal Residual Disease in Muscle-Invasive Bladder Cancer: A Literature Review · 2026 · Related
  7. Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities · Marina Deuker · 2020 · 65 citations · Cited by this paper
  8. Delayed Progression-Free Survival Benefit of Belzutifan Versus Everolimus in LITESPARK-005: A Reconstructed Time-to-Event Reanalysis · 2026 · Related
  9. Circulating tumor DNA (ctDNA) in patients with muscle-invasive bladder cancer (MIBC) who received perioperative durvalumab (D) in NIAGARA. · Thomas B. Powles · 2025 · 45 citations · Cited by this paper
  10. Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma · 2026 · Related
  11. What About Variant Histologies in Bladder Cancer? · Elizabeth A. Day · 2024 · 8 citations · Cited by this paper
  12. Oncologic Outcomes of Robot-Assisted Radical Cystectomy for Variant Histology Bladder Cancer: A Multi-institutional Propensity Score-Matched Analysis · 2026 · Related
  13. Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications · Can Daniel Aydogdu · 2026 · 2 citations · Cited by this paper
  14. Trophoblastic-Differentiated Urothelial Carcinoma: Real-World Sequencing and Clinical Implications · 2026 · Related
  15. Teratoma-Specific Assay Design Enables Detection of Circulating Tumor DNA in Post-chemotherapy Residual Retroperitoneal Disease · 2026 · Related
  16. Association Between Proto-Oncogene N-RAS Transcript Level and Overall Survival in Node-Negative Muscle-Invasive Bladder Cancer · 2026 · Related

Source: OpenAlex (CC0)